Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2022

View Archived Issues

Enanta Pharmaceuticals patents Mpro inhibitors for coronovirus infections

Gilead Sciences describes GLP-1 receptor agonists

New SERD inducers disclosed for treatment of cancer

Lundbeck divulges catecholamine prodrugs for Parkinson's disease

Exscientia describes MALT1 inhibitors

Adropin as novel therapeutic target to attenuate fibroblast activation and fibrosis in SSc

New in vitro data support advancing SLS-004 for dementia with Lewy bodies

Washington University extends research of Hoth's HT-ALZ in mouse model of Alzheimer's disease

Circulating miRNAs associated with difficult-to-treat RA

Novel humanized mouse model of rheumatoid arthritis

Circuit, synuclein insights reported in Parkinson's disease

Senti Biosciences outlines plans for gene circuit technologies and therapeutic pipeline

Advisory board reviews preclinical data for fourth-generation EGFR TKI JIN-A02

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.